These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 42612)

  • 1. Beta receptor blockers on ergometric work in hypertensive patients.
    Franz IW; Lohmann FW; Rocker I; Kothari P
    Indian Heart J; 1979; 31(5):259-62. PubMed ID: 42612
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of a long-term cardioselective and noncardioselective beta-receptorblockade on blood pressure, O2-uptake and carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
    Franz IW; Lohmann FW
    Z Kardiol; 1979 Jul; 68(7):503-9. PubMed ID: 473853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of so-called cardioselective and non-cardioselective beta-receptor blockers on the metabolism during ergometric exercise in hypertensive patients].
    Franz IW; Lohmann FW; Koch G; Röcker L
    Verh Dtsch Ges Inn Med; 1978; (84):813-6. PubMed ID: 33508
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-blockers in the treatment of hypertension in elderly patients].
    Lefflerová K; Widimský J; Lupínek Z
    Vnitr Lek; 1991 Feb; 37(2):128-34. PubMed ID: 1673577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients.
    Franz IW; Lohmann FW; Koch G
    J Cardiovasc Pharmacol; 1980; 2(1):35-44. PubMed ID: 6154203
    [No Abstract]   [Full Text] [Related]  

  • 10. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
    Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
    Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-blockaders in the treatment of hypertension in pregnancy].
    Kawecka-Jaszcz K; Skoczeń M
    Kardiol Pol; 1985; 28(5):334-9. PubMed ID: 2864465
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bopindolol versus metoprolol in hypertension.
    Westerman RF; Christensen C; Westheim A; Donker AJ
    Eur J Clin Pharmacol; 1986; 31(3):379-80. PubMed ID: 2878814
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
    Mattioli G; Ricci S; Menozzi A; Teglio V
    Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 17. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
    Safar M; Weiss Y; Chau NP; Kheder A; Levenson J; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2759-60. PubMed ID: 30957
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study with Tobanum and Visken in hypertensive patients.
    Torma Z; Grubic V; Unyi G
    Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
    [No Abstract]   [Full Text] [Related]  

  • 20. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.